Volume 10,Issue 4
Analysis and Discussion on the Influence of Pharmaceutical Science Popularization on Patients’ Medication Compliance and Medication Awareness
Objective: To explore the effect of providing pharmaceutical science popularization to patients in improving their awareness of medication treatment, as well as its impact on their medication compliance. Method: A total of 68 patients were selected for drug therapy, with the implementation period from February 2023 to December 2024. Under the support of sealed envelope sampling method, the subjects were divided into two groups. The control group (34 cases) received routine intervention, while the experimental group (34 cases) received pharmaceutical science popularization. The drug treatment awareness rate, medication compliance, self-management ability score, and incidence of adverse reactions were compared between the groups. Result: The awareness rate of medication treatment in the experimental group (97.06%) was significantly higher than that in the control group (76.47%) (p < 0.05). The medication adherence of the experimental group (97.06%) was higher than that of the control group (79.41%) (p < 0.05). Before intervention, the self-management ability scores between groups were similar (p > 0.05). After intervention, the self-management ability scores of the experimental group (17.65%) were higher than those of the control group (p < 0.05). The incidence of adverse reactions in the experimental group (2.94%) was lower than that in the control group (p < 0.05). Conclusion: Providing pharmaceutical science popularization to patients has a significant effect on increasing awareness of medication treatment, and can improve medication compliance and self-management ability, which is conducive to reducing the incidence of adverse drug reactions and has promotional significance.
[1] Ma H, Zhang F, Qian Q, et al., 2024, The Impact of Pharmaceutical Science Popularization Intervention on Medication Adherence and Quality of Life in Patients with Hypertension. Anti Infective Pharmacy, 21(6): 599–602.
[2] Wang T, Zong H, Cao F, et al., 2023, Analysis of Influencing Factors on Medication Risk in Elderly Patients with Chronic Diseases. Chinese Journal of Chronic Disease Prevention and Control, 31(7): 489–493.
[3] Ju B, Zhang Y, Xu L, et al., 2023, Drug Detail Popularization and Pharmaceutical Service Practice Based on WeChat Platform. Chinese Journal of Hospital Pharmacy, 43(22): 2579–2583.
[4] Zhang T, Yu H, Ma M, et al., 2024, Construction and Application of Pharmaceutical Service Model for Chronic Noncommunicable Disease Patients Based on WeChat Mini Program. Chinese Journal of Materia Medica and Clinical Medicine, 24(20): 1352–1356.
[5] Li X, Hai Y, Song J, et al., 2024, Application Practice of Short Videos in Pharmaceutical Science Popularization Services. Tianjin Science and Technology, 51(8): 96–99.
[6] Pan W, Xu Q, Ding J, et al., 2024, Evaluation of the Effectiveness of Pharmacist-Led Intelligent WeChat Groups in Medication Education for Epilepsy Patients. Chinese Journal of Clinical Pharmacy, 33(10): 726–732.
[7] Wei K, Luo J, Yang Y, et al., 2023, Research on the Service Model of Safe Medication Science Popularization Based on Drug Consultation Architecture. Strait Pharmacy, 35(11): 62–66.
[8] Zeng J, 2024, The Role of Diversified Pharmaceutical Science Popularization in Improving the Quality of Grassroots Pharmaceutical Services. Modern Medicine and Health, 40(10): 1790–1792.
[9] Fang H, Fang M, Huang J, et al., 2024, Establishment and Effectiveness Analysis of Inhalation Medication Education Mode in the Cough and Asthma Pharmacy Service Outpatient Department of a Hospital. Modern Medicine and Health, 40(6): 1069–1071.
[10] Ma J, Gong H, Zhang L, et al., 2023, The Impact of Individualized Medication Education on Medication Adherence and Quality of Life in Patients with Cerebral Infarction. Yunnan Medicine, 44(2): 37–41.
[11] Zhao Y, Zhu W, Jiang Y, 2023, The Influence of Medication Education and Information-Based Follow-Up on the Treatment Effect of Outpatients with Type 2 Diabetes. Diabetes New World, 26(3): 40–43 + 59.